06628.HK
Transcenta Holding Limited
HKSE · Healthcare · Biotechnology · CN
HKD 0.74
+9.70%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.42x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.47x
- Price / sales
- 9.14x
- Price / cash flow
- -3.73x
Enterprise value
- Enterprise value
- HKD 462.3M
- EV / sales
- 13.88x
- EV / EBITDA
- -3.93x
- EV / EBIT
- -2.65x
- Market cap
- HKD 304.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026